Pmv Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -33 | -32 | -32 | |
EBITDA | -19,209 | -21,033 | -21,173 | -21,527 |
EBIT | -19,242 | -21,065 | -21,205 | -21,564 |
Net Income | -18,037 | -21,059 | -21,210 | -17,436 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -17,204 | -19,819 | -18,313 | -18,270 |
Cash | 37,983 | 36,337 | 44,127 | 51,341 |
Basic Shares | 53,280 | 52,993 | 52,010 | 51,952 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -133 | -1,144 | -1,257 | -650 |
EBITDA | -86,206 | -73,665 | -67,701 | -76,725 |
EBIT | -86,339 | -74,809 | -68,958 | -77,040 |
Net Income | -77,742 | -58,709 | -68,960 | -73,317 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -64,170 | |||
Free Cash Flow | -73,606 | -51,937 | -56,619 | -71,744 |
Cash | 37,983 | 40,876 | 37,706 | 108,297 |
Basic Shares | 52,541 | 51,578 | 48,014 | 45,594 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.34 |
2025-09-30 | -$0.40 |
2025-06-30 | -$0.41 |
